A. Alfarone

发表

omparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer

O. Schillaci, R. Passariello, V. Panebianco, 2012 .

Intermittent Androgen Deprivation in the New Era: The Role of Urologist and Oncologist in a Multidisciplinary Team (MDT)

F. Longo, A. Alfarone, 2014 .

Use of 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy (RRP): a potential diagnostic tool for optimal management of erectile dysfunction after RRP.

R. Passariello, V. Panebianco, A. Sciarra, 2009, The journal of sexual medicine.

Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery.

A. Sciarra, S. Cattarino, V. Gentile, 2013, Urologic oncology.

Comparative effect of finasteride and dutasteride on chromogranin A levels.

A. Sciarra, S. Cattarino, V. Gentile, 2010, Anticancer research.

Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR).

R. Passariello, V. Panebianco, A. Sciarra, 2012, Urologic oncology.

459 DETERMINATION OF THE TIME FOR MAXIMAL RESPONSE TO NEOADJUVANT HORMONE THERAPY (LEUPROLIDE) FOR PROSTATE CANCER USING MAGNETIC RESONANCE WITH SPECTROSCOPY (MRSI) AND DYNAMIC CONTRAST ENHANCEMENT (DCEMR)

R. Passariello, V. Panebianco, A. Sciarra, 2010 .

Early recovery of urinary continence after radical prostatectomy using early pelvic floor electrical stimulation and biofeedback associated treatment.

A. Sciarra, V. Gentile, G. D. Di Pierro, 2009, The Journal of urology.

Actual role of multitargeted therapy in renal cell carcinoma (RCC)

A. Sciarra, V. Gentile, A. Alfarone, 2008 .

Allium stent as a curative treatment for benign ureteral strictures: Preliminary experience, surgical technique, and functional results

A. Sciarra, M. Maggi, F. Del Giudice, 2022, Frontiers in Urology.

Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer.

O. Schillaci, R. Passariello, V. Panebianco, 2012, Critical reviews in oncology/hematology.

Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve-sparing radical prostatectomy.

R. Passariello, V. Panebianco, A. Sciarra, 2012, The journal of sexual medicine.

2055 USE OF MULTIPARAMETRIC MR WITH NEUROVASCULAR BUNDLE EVALUATION TO OPTIMIZE THE ONCOLOGICAL AND FUNCTIONAL MANAGEMENT OF PATIENTS CONSIDERED FOR NERVE SPARING RADICAL PROSTATECTOMY

V. Panebianco, A. Sciarra, S. Cattarino, 2012 .

“Prostate Cancer Unit” for an Optimal Management of Prostate Cancer

V. Panebianco, A. Sciarra, S. Cattarino, 2012, Urologia.

Benign Prostatic Hypertrophy: A Progressive Pathology. Hypothesis for a Preventive Therapy

A. Sciarra, G. D. Di Pierro, A. Alfarone, 2006 .

707 VALUE OF MAGNETIC RESONANCE SPECTROSCOPY IMAGING (MRSI) AND DYNAMIC CONTRAST-ENHANCED IMAGING MR (DCEMR) FOR THE DETECTION OF PROSTATE ADENOCARCINOMA FOCI IN MEN WITH PRIOR NEGATIVE PROSTATE BIOPSY AND ELEVATED PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS

R. Passariello, V. Panebianco, A. Sciarra, 2010 .

Supernumerary kidney laparoscopically treated.

P. Casale, A. Sciarra, S. Cattarino, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Update on screening in prostate cancer based on recent clinical trials.

A. Sciarra, S. Cattarino, V. Gentile, 2011, Reviews on recent clinical trials.

Oral ethinylestradiol in castration‐resistant prostate cancer: A 10‐year experience

A. Sciarra, S. Cattarino, V. Gentile, 2015, International journal of urology : official journal of the Japanese Urological Association.

New anti-angiogenic targeted therapy in advanced renal cell carcinoma (RCC): current status and future prospects.

A. Sciarra, V. Gentile, A. Alfarone, 2008, Reviews on recent clinical trials.

Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer.

R. Passariello, V. Panebianco, A. Sciarra, 2011, Urologic oncology.

The emerging role of targeted therapy in renal cell carcinoma (RCC): is it time for a neoadjuvant or an adjuvant approach?

A. Sciarra, S. Cattarino, V. Gentile, 2012, Critical reviews in oncology/hematology.

Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy

Roberto Passariello, Valeria Panebianco, Alessandro Sciarra, 2010, Clinical Cancer Research.

Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer.

R. Passariello, V. Panebianco, A. Sciarra, 2010, Cancer investigation.

Magnetic Resonance Spectroscopic Imaging (1H-MRSI) and Dynamic Contrast-Enhanced Magnetic Resonance (DCE-MRI): Pattern Changes From Inflammation to Prostate Cancer

R. Passariello, V. Panebianco, A. Sciarra, 2010 .

Distribution of High Chromogranin A Serum Levels in Patients with Nonmetastatic and Metastatic Prostate Adenocarcinoma

A. Sciarra, V. Gentile, A. Alfarone, 2009, Urologia Internationalis.

Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci.

R. Passariello, V. Panebianco, A. Sciarra, 2011, Urologic oncology.

Role of Neuroendocrine Cells in Prostate Cancer Progression

V. Panebianco, A. Sciarra, S. Cattarino, 2011, Urologiâ.

Neuroendocrine Target Therapies for Prostate Cancer

A. Sciarra, G. Monti, S. Cattarino, 2011, Urologia.

Androgen Deprivation Therapy and Neuroendocrine Differentiation in Prostate Carcinoma – A Possible Inductive Role

A. Sciarra, L. Albanesi, A. Alfarone, 2006 .